The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …

The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …

The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …

The spread of the Omicron SARS-CoV-2 variant underscores the importance of analyzing
the cross-protection from previous non-Omicron infection. We have developed a high …

The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa,. It has in the meantime spread to many countries and is expected to rapidly …

SARS-CoV-2 variants accumulating immune escape mutations provide a significant risk to
vaccine-induced protection against infection. The novel variant of concern (VoC) Omicron …

Abstract The SARS-CoV-2 Omicron variant was first identified in November 2021 in
Botswana and South Africa,–. It has since spread to many countries and is expected to …

In late November 2021, the World Health Organization declared the SARS-CoV-2 lineage B.
1.1. 529 the fifth variant of concern, Omicron. This variant has acquired over 30 mutations in …

Omicron, the SARS-CoV-2 B. 1.1. 529 variant of concern (VOC), was first detected in
southern Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK …

Background Rapid spread of the omicron SARS-CoV-2 variant despite extensive
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …